UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.93 +0.45 (+0.57%) GOLD FUTURES
2,321.80 -9.40 (-0.40%) DOW
38,945.87 +93.60 (+0.24%) Bitcoin GBP
50,641.90 +67.20 (+0.13%)
Aytu BioPharma, Inc. (AYTU)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:19PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 17.20M |
| Enterprise value | 13.72M |
| Trailing P/E | N/A |
| Forward P/E | 6.18 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.15 |
| Price/book (mrq) | 0.52 |
| Enterprise value/revenue | 0.14 |
| Enterprise value/EBITDA | 4.43 |
Trading information
Stock price history
| Beta (5Y monthly) | -1.26 |
| 52-week change 3 | 49.27% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 3.5000 |
| 52-week low 3 | 1.3800 |
| 50-day moving average 3 | 2.9774 |
| 200-day moving average 3 | 2.5612 |
Share statistics
| Avg vol (3-month) 3 | 21.7k |
| Avg vol (10-day) 3 | 12.36k |
| Shares outstanding 5 | 5.57M |
| Implied shares outstanding 6 | 5.57M |
| Float 8 | 3.8M |
| % held by insiders 1 | 3.49% |
| % held by institutions 1 | 31.80% |
| Shares short (15 Apr 2024) 4 | 402.51k |
| Short ratio (15 Apr 2024) 4 | 18.63 |
| Short % of float (15 Apr 2024) 4 | 7.49% |
| Short % of shares outstanding (15 Apr 2024) 4 | 7.23% |
| Shares short (prior month 15 Mar 2024) 4 | 361.56k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 09 Dec 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 06 Jan 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -18.27% |
| Operating margin (ttm) | 10.31% |
Management effectiveness
| Return on assets (ttm) | -2.58% |
| Return on equity (ttm) | -45.75% |
Income statement
| Revenue (ttm) | 98.5M |
| Revenue per share (ttm) | 21.04 |
| Quarterly revenue growth (yoy) | -12.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 3.09M |
| Net income avi to common (ttm) | -18M |
| Diluted EPS (ttm) | -4.0100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 19.53M |
| Total cash per share (mrq) | 3.51 |
| Total debt (mrq) | 18.26M |
| Total debt/equity (mrq) | 55.57% |
| Current ratio (mrq) | 1.11 |
| Book value per share (mrq) | 5.90 |
Cash flow statement
| Operating cash flow (ttm) | 6.11M |
| Levered free cash flow (ttm) | 11.39M |
© 2024 Yahoo. All rights reserved.